文献速递肺结节与肺癌

血清25-羟基维生素D水平与肺癌及组织学类型风险的孟德尔随机化分析:HUNT研究

Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study.
PubMed 文献 · Eur Respir J · 2018-06-07

该研究基于挪威HUNT前瞻性队列(54 580人,676例肺癌),利用维生素D升高等位基因构建等位基因评分进行孟德尔随机化分析。结果显示基因决定的25(OH)D水平与肺癌总体及组织学类型发病风险均无因果关联。

要点

  • 等位基因评分解释血清25(OH)D水平变异的3.4%。
  • 基因决定的25(OH)D每升高25 nmol·L-1,肺癌总体发病风险无显著关联(HR 0.96,95%CI 0.54-1.69)。
  • 孟德尔随机化分析未提示25(OH)D水平与肺癌总体或各组织学类型风险存在因果关联。

核心结论

  • 孟德尔随机化分析未提示血清25(OH)D水平与肺癌总体或组织学类型风险存在因果关联。

研究设计与样本

  • 前瞻性队列研究(挪威HUNT研究),纳入54 580人,其中676例肺癌 incident cases。
  • 基于rs2282679、rs12785878和rs10741657构建维生素D升高等位基因评分。
  • 采用逆方差加权法(基于单个SNP汇总数据)计算孟德尔随机化估计值。

主要发现

  • 等位基因评分解释血清25(OH)D水平变异的3.4%。
  • 等位基因评分与肺癌总体发病风险无关联(HR 0.99,95%CI 0.93-1.06,每等位基因评分)。
  • 基因决定的25(OH)D每升高25 nmol·L-1,与肺癌总体发病风险无关联(MR估计HR 0.96,95%CI 0.54-1.69),与任何组织学类型亦无关联。

临床怎么用

  • 基于本孟德尔随机化结果,不支持通过升高25(OH)D水平来预防肺癌。
  • 临床解读25(OH)D与肺癌风险关系时需注意观察性研究可能受混杂影响。

局限性

  • 等位基因评分仅解释血清25(OH)D水平变异的3.4%,工具变量效力有限。
  • 研究基于挪威人群,外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to investigate potential causal associations between serum 25-hydroxyvitamin D (25(OH)D) levels and incidence of lung cancer overall and histologic types.We performed a Mendelian randomisation analysis using a prospective cohort study in Norway, including 54 580 individuals and 676 incident lung cancer cases. A 25(OH)D allele score was generated based on the vitamin D-increasing alleles rs2282679, rs12785878 and rs10741657. Hazard ratios with 95% confidence intervals for incidence of lung cancer and histologic types were estimated in relation to the allele score. The inverse-variance weighted method using summarised data of individual single nucleotide polymorphisms was applied to calculate the Mendelian randomisation estimates.The allele score accounted for 3.4% of the variation in serum 25(OH)D levels. There was no association between the allele score and lung cancer incidence overall, with HR 0.99 (95% CI 0.93-1.06) per allele score. A 25 nmol·L-1 increase in genetically determined 25(OH)D level was not associated with the incidence of lung cancer overall (Mendelian randomisation estimate HR 0.96, 95% CI 0.54-1.69) or any histologic type.Mendelian randomisation analysis did not suggest a causal association between 25(OH)D levels and risk of lung cancer overall or histologic types in this population-based cohort study.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Sun YQ, Brumpton BM, Bonilla C, et al. Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study. Eur Respir J. 2018. PMID: 29748306. doi:10.1183/13993003.00329-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。